When a peptide vendor displays a Certificate of Analysis (COA) with a "verified" badge or a clickable portal link, it signals that the document was issued by a third-party laboratory rather than produced in-house. That distinction matters. But the word "verified" covers a narrow technical act — confirmation that a report with a given reference number exists in a lab's own database — and it says nothing about several things buyers often assume it does.
What Report Verification Actually Does
Independent testing labs such as Janoshik operate publicly accessible verification portals where anyone can enter a report's reference number and confirm that the lab did, in fact, issue a document with that identifier. The check answers one question: *is this report in our system?* A positive result rules out the most straightforward form of fraud — a vendor fabricating a document from scratch and attaching a realistic-looking lab name and number.
Labs that publish verification portals typically also display the core findings associated with that reference number: compound name, reported purity percentage, and the analytical method used (commonly HPLC — High-Performance Liquid Chromatography — for purity, and MS or mass spectrometry for identity confirmation). Some portals additionally show the sample submission date and the client name or order number.
What Verification Does Not Prove
Portal verification confirms the report is real. It does not confirm:
| Question | What verification says |
|---|---|
| Was the sample submitted by this vendor? | Unknown — any party can submit under any label |
| Does the vial you received match the tested sample? | Not addressed |
| Was the sample cherry-picked from a batch? | Not addressed |
| Is the compound free of biological contaminants (endotoxins, sterility)? | Only if those specific tests appear on the COA |
| Is the compound appropriate for human use? | Not addressed — research peptides are sold for research use, not approved for human consumption |
The most consequential gap is chain of custody. A COA is issued on a sample the lab received; it cannot, by design, certify that the product in a customer's order came from the same production lot. Independent aggregator sites such as Peptigrity publish the raw data as submitted; they do not audit the vendor's fulfillment process.
A second gap involves test scope. HPLC purity readings measure the proportion of the target peptide peak relative to total detected peaks in a solution. A sample can show 99% purity by HPLC while still containing endotoxins, residual solvents, or microbial contamination that HPLC does not detect. Buyers should check whether a COA includes supplementary panels — LAL endotoxin testing, residual solvent analysis, or microbial limits — before treating a purity figure as a comprehensive safety profile.
How to Read a COA More Critically
Community aggregation projects such as VialAudit and PeptideBenchmark independently purchase and retest samples from vendors, then publish results alongside the vendor-supplied COA. Where those independent results diverge from the vendor's own documentation, the discrepancy is documented publicly. Comparing a vendor COA against independently commissioned tests — where available — provides a stronger basis for assessing consistency than portal verification alone.
Pharmacopoeial bodies including USP and EP (European Pharmacopoeia, published by EDQM / Council of Europe) publish reference standards and method guidance for peptide characterisation. Pharmaceutical-grade manufacturers such as Bachem and PolyPeptide publish technical documentation on their quality systems. Research-grade vendors operate under different regulatory frameworks and are not held to the same standards, a distinction that verification portals do not surface.
When reading any COA, the most informative questions are: which tests were run, by which method, on which date, and who submitted the sample? Portal verification answers the last part partially. The rest requires reading the document itself.